PathologyWatch Raises $2M in Extension Funds to Bolster Pathology AI Research Share Article Funding Led by Neue Fund and BioVentures Investors to extend AI research and allow strategic life science and AI investors into the round. Our confidence couldn’t be higher in their ingenuity and devotion to advancing the digital dermatopathology landscape. SALT LAKE CITY (PRWEB) December 16, 2020 PathologyWatch has announced $2M in extension funding from Neue Fund, Bioventures GmbH, Lateral Capital, BeniVC, and Sky Ventures. PathologyWatch will direct the capital towards digital dermatopathology development and scaling the laboratory system to extend AI research and to allow additional strategic life science and AI investors into the round.